Precision Dynamics competitors

I am the Chief Executive Officer, President and Chairman of Abiomed, Inc. (NASDAQ: ABMD), the only medical device company focused solely on heart recovery. At Abiomed, we are driven by our four principles: recovering hearts and saving lives, leading in technology and innovation, growing shareholder value and sustaining a winning culture of putting patients first. As a U.S. military veteran, I also serve as Co-Founder and Chairman of the Mentoring Veterans Program (MVPvets), a nonprofit organization committed to helping military veterans network with industry mentors to discover career opportunities in the life sciences industry.

Michael F. Mahoney is a Director on the board of the Boys & Girls Club of Boston. He is the Chairman and CEO of Boston Scientific.

Michael A. Mussallem, age 56, has been chairman and CEO of Edwards Lifesciences, Inc. since 2000. Prior to 2000, Mussallem held a variety of positions with increasing responsibility in engineering, product development and senior management at Baxter International Inc., including Group Vice President of its CardioVascular business from 1994 to 2000 and Group Vice President of the Biopharmaceutical business from 1998 to 2000. From 1996 until 1998, he was the Chairman of Baxter's Asia Board overseeing Baxter's operations throughout Asia. Mr. Mussallem is chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed), and serves as a member of the board for Advanced Medical Optics. He is also on the boards and executive committees of the California Healthcare Institute and OCTANe, and is a trustee of the University of California, Irvine Foundation. He received a bachelor's degree in chemical engineering in 1974 and an honorary doctorate in 1999 from the Rose-Hulman Institute of Technology in Indiana.

Eric became chief executive officer and a member of the board of directors of IDEX Corporation in December 2020 after becoming president in February 2020. He was previously chief operating officer beginning in 2015. He has been integral to the company’s success, including his role in developing the company’s distinct culture, business model and strategy. He joined IDEX in 2008 as the president of Gast Manufacturing, an operating unit that produces high-quality, niche pneumatics. In 2010, he added responsibilities for Global Dispensing, the leading provider of automated color tinting solutions within the architectural coatings market. He received his first group executive role in 2012, with a collection of six companies from within two IDEX reporting segments. In the next few years, Eric and his teams developed and piloted the elements of the IDEX Operating Model and began work with 8020, an approach to business that focuses on the vital few variables that drive the greatest degree of impact. In 2014, he expanded his group executive scope into the IDEX Health & Science and Optics businesses. Eric is passionate about developing high-performing global teams and talent. Many of IDEX’s current senior operating leaders were identified as emerging leaders within his group. Prior to joining IDEX, he served as the president of Schutt Sports, the market leader for protective equipment in American football. The company introduced breakthrough helmet technology during his tenure, capturing share at all levels of competition. Prior to Schutt, Eric led teams within operations and general management at three business units of Danaher Corporation. It was here, in tough turnaround situations, that he developed the ability to focus teams around the critical few business levers to drive quick momentum and progress. Prior to Danaher, he worked within scalable operations roles at AlliedSignal/Honeywell. He began his career within manufacturing at Lincoln Brass Works. Eric received a bachelor’s degree in economics and an MBA from the University of Michigan. He has a passion for history and literature, and he is a lifelong, practicing musician who spends much of his free time playing and recording. Eric and his wife live in the Chicago area, where they enjoy travel, the arts, and a seemingly endless loop of home maintenance and rehabilitation of their 1920’s-era home. They have four grown children. Eric is also a director of Modine Manufacturing Co.

Scott Flora has more than 40 years of healthcare experience in surgical devices and is currently serving as Board Chair for Palliare Ltd and New View Surgical. He is also on the Board of Conventus/Flower Orthopaedics. Prior to that Scott held the following leadership roles, Interim President and CEO of Invuity, Executive Director of Conventus Orthopaedics, President and CEO of OmniGuide Surgical, President of Covidien's Surgical Device Group ,President Smith& Nephew Orthopedic Reconstruction, General Manager Smith&Nephew Trauma , Sr. V.P. Sales US and Europe, Global V.P. Sales & Marketing Ioptex Research. Scott has also served on three public company boards, Invuity, MAKO Surgical and Tengion. Scotts skills have been demonstrated in:Building Effective TeamsInnovation ManagementResults OrientedStrategic AgilityBuilding a Strong Vision supported by ValuesGlobal LeadershipCommercial ExecutionGovernance

John F. Sheridan has served as our President and Chief Executive Officer since March 2019 and as a member of our Board of Directors since June 2019. Prior to joining our company, Mr. Sheridan served as Chief Operating Officer of Rapiscan Systems, Inc., a provider of security equipment and systems, from March 2012 to February 2013. Mr. Sheridan served as Executive Vice President of Research and Development and Operations for Volcano Corporation (NASDAQ: VOLC), a medical technology company, from November 2004 to March 2010. From May 2002 to May 2004, Mr. Sheridan served as Executive Vice President of Operations at CardioNet, Inc., a medical technology company. From March 1998 to May 2002, he served as Vice President of Operations at Digirad Corporation, a medical imaging company. Mr. Sheridan holds a B.S. in Chemistry from the University of West Florida and an M.B.A. from Boston University.

Joined Varian as an intern in 1999, then full time in 2001, and has held multiple cross-functional roles and executive positions during two-decade tenure with the company. Intimate understanding of healthcare, software solutions, medical devices, technology trends, reimbursement trends and strategies that lead to success in targeted channel segments globally. Marketing strategy, new product launch, portfolio strategy, M&A, P&L, restructuring, government relations, and general management experience. Consistent creation of strategies and execution against operating plans, sales goals and market objectives, including extensive experience of both high growth and slow growth periods (turnaround plans) of Varian Medical Systems journey from $500M to over $3B. Including returning Varian to double digit growth following becoming President of the $3B+ P&L of Oncology systems. Strong leadership skills with a track record of creating an inspiring vision and communicating effectively both internally/externally through developing cultural, servant leadership and focusing on people/teams to drive net promoter scores to all-time highs and enable sustainable long-term success.